Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models.
about
Metformin and AMP Kinase Activation Increase Expression of the Sterol Transporters ABCG5/8 (ATP-Binding Cassette Transporter G5/G8) With Potential Antiatherogenic Consequences.Activation of AMPK for a Break in Hepatic Lipid Accumulation and Circulating Cholesterol.AMPK Activation Reduces Hepatic Lipid Content by Increasing Fat Oxidation In Vivo
P2860
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Activation of Liver AMPK with ...... nd Primate Preclinical Models.
@en
Activation of Liver AMPK with ...... nd Primate Preclinical Models.
@nl
type
label
Activation of Liver AMPK with ...... nd Primate Preclinical Models.
@en
Activation of Liver AMPK with ...... nd Primate Preclinical Models.
@nl
prefLabel
Activation of Liver AMPK with ...... nd Primate Preclinical Models.
@en
Activation of Liver AMPK with ...... nd Primate Preclinical Models.
@nl
P2093
P2860
P1433
P1476
Activation of Liver AMPK with ...... and Primate Preclinical Models
@en
P2093
Alan Opsahl
Allan Reyes
Amit S Kalgutkar
Bina Albuquerque
Brennan K Smith
Christopher T Salatto
Chuong Nguyen
David Tess
Eliza Bollinger
Emily A Day
P2860
P304
P356
10.1016/J.EBIOM.2018.04.009
P577
2018-04-08T00:00:00Z